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1. INTRODUCTION 
 
1.1. Chronic wounds and leg ulcers 
The number of chronic wound patients is increasing world wide, despite 
the fact that the last twenty years have seen major innovations in wound 
healing. Unfortunately this also means a steep rise in the number of 
lower limb amputations due to previous tissue loss. Chronic wounds are 
a growing challenge due to demographic changes and increased risks of 
atherosclerosis and diabetes. In developing countries the prevalence of 
diabetes is about 5-7%, and it is estimated that 15% of all diabetic foot 
ulcers will result in amputations. Both tissue loss and amputations have 
an enormous impact on one’s everyday life resulting in social isolation, 
loss of independence, psychological stress and increased health costs for 
the patient and the society as well. These health costs already present a 
significant economic problem for health care providers, and with the 
patient numbers increasing they forecast a boom in expenses in the near 
future. The abundance of wound care methods and products resulted in 
an information boom regarding wound healing, making every day 
decision making harder. Treating a wound properly now equals to 
establishing a complex care strategy for the patient with the involvement 
of a multidisciplinary wound care team. 
 
1.2. Overview of advanced wound care 
The basic goals of chronic wound care: first - treat the cause, second - 
apply adequate local wound care. In the case of acute wounds normal 
wound healing is described as a cascade of physiological events 
resulting in full epithelisation. In chronic wounds these events often take 
place not one by one, but at the same time. A chronic wound is defined 
as a break in the skin of long duration (more than 6 weeks). Analyzing a 
chronic wound, one must attempt to determine which aspect of the 
healing process gone wrong and why. It should be carefully assessed 
whether it is the result of local or systemic microenvironmental factors. 
With this approach, chronic wound can be considered as a symptom of 
an underlying disease. For most cases successful wound healing is based 
on two pillars (goals): treating the underlying cause or disease behind 
the chronic wound and adequate local wound care resulting in a wound 
bed ready for epithelisation. The basic goal of local wound care is to 
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prepare a wound bed ready for epithelisation in the shortest, safest, pain 
free manner in the most cost-effective way possible. The main goal of 
these wound dressings is to maintain and protect a moist wound 
environment with the possible capability to absorb the excess exudates 
to prevent maceration. Besides the use of modern moist wound 
dressings, a wide array of wound care methods have been developed to 
solve common wound bed disorders. Evidently, accomplishment of only 
one of these two goals will never result in long term success. 
 
1.3. The non-healing wound: could leg ulcers be hereditary? 
The ulceration of the leg is a multifactorial disorder with several known 
and yet unknown environmental and genetic factors contribute to its 
etiology. To study the genetic factors involved in the mechanism of leg 
ulcer development and to minimize statistical bias, we have chosen one 
of the major homogenous subgroup of leg ulcers; therefore our genetic 
studies were carried out on patients with venous leg ulcer. The 
complexity of venous leg ulcer pathogenesis is increased by the fact that 
in the majority of the cases its development has polyetiological origin. 
Besides environmental factors, several predisposing genetic factors have 
already been shown to be associated with venous leg ulcer susceptibility 
such as the presence of certain gene polymorphisms and gene 
expression abnormalities. The known genetic factors predisposing to 
venous leg ulcer development are the followings factor V Leiden 
mutation, prothrombin gene G20210A mutation, antithrombin 
deficiency, activated protein C resistance, protein S deficiency, 
hyperhomocysteinaemia and abnormal TGF-β type 2 receptor 
expression (Munkvad et al., 1996; Peus et al., 1997). These genetic 
factors impair different processes and phases of wound healing, which 
might suggest that multiple molecular mechanisms of venous leg ulcer 
development exist or similarly to carcinogenesis the co-existence of 
different precipitating factors leads to the development of the disease. 
To develop causative treatment opportunities for those who have genetic 
deficiencies in the pathogenesis, there is an emerging importance to 
characterize the genetic abnormalities of leg ulcer development. 
 
1.4. Aims  
The aims of our genetic studies were to identify common single 
nucleotide polymorphisms (SNP), which are associated with leg ulcer 
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development and gene expression abnormalities related to pathologic 
wound healing. 
We also aimed to develop a new autologous skin cell transplantation 
method that makes use of hairy scalps as a donor site, with an artificial 
mitogen free culturing method containing melanocytes, fibroblasts and 
keratinocytes. 
 
2. MATERIALS AND METHODS 
 
2.1. Human skin biopsy samples for genetic studies 
Two-by-two cm shave biopsies were collected under local anesthesia 
from venous leg ulcer patients (n=15) and from age and sex-matched leg 
ulcer-free control individuals (n=15). The average duration of the ulcers 
was 5.8±5.1 years and 24.2% of the leg ulcer patients had suffered from 
deep vein thrombosis previously. Leg ulcer patients of other causes 
were excluded from the study. Venous leg ulcer patients were also 
screened a series of other diseases, for example trauma, erysipelas, 
cardiac diseases, atherosclerosis and autoimmune disorders. The study 
was approved by the Internal Review Board. Written informed consent 
was collected from all the donors. The study was conducted according 
to the Principles of the Declaration of Helsinki.  
 
2.2. SNP detection  
Blood samples were collected from patients with leg ulcer (n=82, 
average age: 67.0±24.8 years) and from the members of an age-matched 
control group (n=82, average age: 53.0±29.2 years). DNA was isolated 
by standard proteinase K digestion (DNA Isolation Kit, Eppendorf). 
PCR reactions were carried out on all of the samples with TaqMan 
mutation detection probes (Assays-on-Demand SNP Genotyping Kit, 
Applied Biosystems). The Assays-On-Demand SNP Analysing Mix 
contains two main components: specific primers for the amplification of 
a short DNA fragment involving the examined SNP and 
oligonucleotides labelled with fluorescent dyes (FAM and VIC). The 
sequences of the labelled oligonucleotides differ from each other only in 
one nucleotide, which is in the position of the polymorphism. During 
the PCR reaction, one or both of the oligonucleotides bind to the DNA 
amplicon, depending on the genotype of the examined individual, and is 
cut into fragments by the exonuclease activity of the Taq DNA 
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polymerase. Thus, at the end of the PCR reaction, the fluorescent signal 
of one or both of the cut fragments can be detect After the PCR reaction. 
End-point detection was performed with an ABI Prism 7000HT 
Sequence Detection System. The statistical significance of the 
differences between data distributions was determined by using the Chi2 
probe and a probability level P<0.05 was considered statistically 
significant. 
 
2.3. Gene expression at mRNA level – real-time RT-PCR 
Total RNA was isolated from samples through the use of the TRIzol 
reagent, following the instructions of the manual. cDNAs werw 
generated with oligo(dT) and random hexamer primers from 1 µg of 
RNA, using the iScriptTM cDNA Synthesis Kit of Bio-Rad 
Laboratories (Hercules, CA, USA) in a final volume of 20 µl. Then real-
time RT-PCR was performed to quantify the abundance of the mRNA 
levels of the studied genes. RNA expression data were normalized to the 
18S ribosomal RNA expression data of each of the examined samples. 
TaqMan probes were purchased from IDT Probes (Chicago, IL, USA). 
The real-time RT-PCR reactions were conducted by using iQ Supermix 
(Bio-Rad Laboratories) in an iCycler (Bio-Rad Laboratories). 
 
2.4. Gene expression at protein level – Western blot analysis 
Total protein extracts were prepared from the skin biopsy samples using 
TRIzol reagent according to the instruction of the manual. In order to 
verify the equivalent loading of proteins in the wells, the following 
procedure was carried out: based on the measured density OD280, the 
protein concentration of each sample was calculated and the samples 
were then run on 10% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). The gels were stained with Coomassie brilliant blue (CBB; 
Sigma-Aldrich), dried and scanned. The lanes were analyzed by 
densitometry. The amounts of the loaded protein samples were corrected 
according to the densitometry data and checked again on SDS-PAGE. 
 
2.5. Statistical analysis 
Statistical analysis, on the groups of leg ulcer patients and leg ulcer-free 
controls, was carried out according to the rules of case-control allelic 
association study design. The statistical significance of the association 
between the mRNA or protein expression profiles of the different genes 
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and venous leg ulcer development was assessed by one-way ANOVA 
for two independent samples. The statistical significance of the 
association between the studied SNPs of FGFR2 and venous leg ulcer 
was determined with the Chi2 probe. The Bonferroni correction for the 
multiple hypothesis of the analysed different SNPs (n=5) was also 
defined. The statistical significance of the association between the -308 
TNF-α SNP and venous leg ulcer was calculated by means of the Fisher 
Exact Probability Test. To allow comparison with the findings of 
Wallace et al. (2006), logistic regression analysis was also carried out. 
For all SNPs the odds ratios (ORs) with 95% confidence intervals (CIs) 
were also determined. 
 
2.6. Human skin biopsy samples for culturing 
We took biopsies from six patients after approval of the study protocol 
by the Ethical Commitee of the University of Szeged. All patients were 
informed of the procedures and all have signed the consent form. The 
samples were taken from three different sites under local anesthesia: 
split skin graft of the hairy scalp, full thickness graft of the groin and 
split thickness graft of the upper leg. All samples were 9 cm2 in size. 
Each individual (ages 61-74) had chronic leg ulcers for over 10 years. 
 
2.7. Cell culturing and autolgous keratinocyte transplantation 
Adult epidermal keatinocytes and melanocytes were isolated and 
cultured from the groin, thigh and hairy scalp of healthy Caucasian 
donors. Skin specimens were first washed in Salsol A solution (Human 
Rt, Gödöllő, Hungary) supplemented with 2% antibiotic, antimycotic 
solution (Sigma). The subcutis and part of the dermis was removed and 
the tissue was cut into small strips. Overnight incubation in Dispase 
solution (Grade II, Roche Diagnostics, Mannheim, Germany) was 
carried out at 4 °C to separate the dermis from the epidermis (Kitano et 
al, 1983). Next day the epidermis was peeled of the dermis. The 
epidermis was put into 0.25% trypsin (Gibco) for 30 minutes at 37 °C. 
Following trypsinization, the epidermis was mechanically torn apart and 
vigorously washed to release epidermal cells. The epidermal cell 
suspension was filtered through a 100 µm nylon mesh (BioDesign, 
Saco, Maine, USA) and centrifuged at 200g for 10 minutes at 4 °C. 
Epidermal cells were then placed into 75 cm2 tissue culture dishes 
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(Corning Incorporated, Corning, NY, USA) at a cell density of 4x105 
cells/cm2. Cells were washed with fresh culture medium 12-18 hours 
after seeding to remove floating cells from the culture. Fresh culture 
medium was put on cells three times weekly. Primary cultures reached 
~90% confluence in 7–9 days. Confluent primary cultures were treated 
with 0.05% EDTA in PBS and cells were harvested by a short, 1-2 
minute trypsinization with 0.01 % trypsin (Gibco). Harvested cells were 
divided into two aliquots at passages. The cultures were grown at 37 °C 
in humidified atmosphere containing 5% CO2. Keratinocyte and 
melanocyte co-cultures have been established and expanded from the 
different donor sites selectively in vitro. Patients were transplanted with 
autologous keratinocytes using the Tissucol® system from Baxter. 
 
3. RESULTS 
 
3.1. SNP of the 3’ untranslated region of the FGFR2 gene (2451A/G) 
Comparison of the SNP data on venous leg ulcer patients (n=82) with 
those on healthy individuals (n=82) we identified an SNP located in the 
3’ untranslated region (UTR) of FGFR2 (2451A→G; 900 bp 
downstream from the open reading frame) which displayed a significant 
difference in the allelic distribution between the leg ulcer patients and 
the healthy individuals (P=0.0103). Our results allow to conclude that 
expression of the FGFR2-IIIb isoform is related to the proliferation 
states of the keratinocytes. The fact that FGFR2-IIIb exhibits a lower 
expression level in venous leg ulcer patients suggests a receptor 
dysfunction which, through impairment of the proliferation phase of re-
epithelization, leads to pathologic wound healing in these patients. A 
possible underlying mechanism for the abnormal expression of FGFR2-
IIIb seen in venous leg ulcer patients may be the presence of the 2451 
A/G 3’UTR SNP, which could alter the stability of the mRNA and 
results in decreased amounts of FGFR2 protein and receptor 
dysfunction. In this case, both the re-epithelization through FGFR2-IIIb 
and the angiogenesis through FGFR2-IIIc may be impaired. 
 
3.2. Gene expression abnormalities 
Syndecan 4 (SDC4), a heparan sulfate proteoglycan, and neuropilin-1 
(NRP1), a transmembrane receptor, are both involved in normal wound 
healing, but little is known about their possible role in venous leg ulcer 
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pathogenesis. We aimed to study whether there are expression 
abnormalities and/or gene polymorphisms of SDC4 and NRP1 
associated with venous leg ulcer. SDC4 showed significantly lower 
mRNA and protein expression levels in the uninvolved dermis of 
venous leg ulcer patients (n=15) as compared to the control (n=15; 
P=0.0136), while NRP1 showed no expression abnormalities. We 
hypothesize that SDC4 may play an essential role not only in the 
inflammation and tissue formation phases of normal wound healing, but 
its expression abnormalities observed in the uninvolved dermis of 
venous leg ulcer patients may contribute to venous leg ulcer 
development. 
 
3.3. Artificial chemical mitogen free method to culture human adult 
melanocytes and keratinocytes 
In Mel-mix medium (AIM-V and Keratinocyte Basal Medium (KBM) 
(v:v) supplemented with 2.5% fetal bovine serum, 2.5 ng/ml epidermal 
growth factor, 25 µg/ml bovine pituitary extract) normal human adult 
keratinocytes and melanocytes grew in vitro without chemical mitogens. 
To compare the cultured cells to cells grown in conventional TPA 
containing medium melanocytes from the same skin specimen were 
cultured simultaneously with 10 ng/ml TPA in the complete Mel-mix 
medium. Melanocytes cultured in the presence of TPA had a highly 
dendritic appearance showing multiple dendritic processes, well 
developed ramifications and an overall delicate architecture compared to 
their TPA-free counterparts. Multiple contacts were present between the 
cells grown with TPA. Melanocytes cultured in the TPA-free medium 
also showed the typical dendritic appearance, however the dendritic 
projections were notably more voluminous and cell contacts were 
notably less. As both culture types matured and grew toward 
confluency, cells started to show a tripolar or bipolar spindle-shaped 
morphology. Cells typically became polygonal and flat in senescence in 
both cultures.  
 
3.4. Hairy scalp the ideal donor site for split thickness and 
autologous keratinocyte-melanocyte transplantation 
Analyses of freshly isolated keratinocytes from hairy scalp skin showed 
that the percentage of p63 positive cells was significantly higher 
(39.8±12.0%) as compared to upper leg (31.7±8.3%, P=0.007) or groin 
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(27.8±16.0, P=0.03). Percentage of the K1/K10 negative cells was also 
significantly higher (52.6±10.2%) than in the case of keratinocytes 
separated from groin (35.4±4.5%, P=0.018) or from the upper leg 
(36.1±3.2%, P=0.028). Moreover hairy scalp yielded a higher number of 
epidermal cells from the same size of skin specimen 
 
 
4. DISCUSSION 
 
4.1. Genetic studies 
Leg ulceration is a multifactorial disorder with several known and yet 
unknown environmental and genetic factors contribute to its etiology. 
Our genetic studies concerned a homogenic subgroup of leg ulcers, to 
venous leg ulcers. However the complexity of venous leg ulcer 
pathogenesis is increased by the fact that in the majority of the cases its 
development has polyetiological origin. Besides environmental factors, 
several predisposing genetic factors have already been shown to be 
associated with venous leg ulcer susceptibility such as the presence of 
certain gene polymorphisms and gene expression abnormalities. These 
genetic factors impair different processes and phases of wound healing, 
which might suggest that multiple molecular mechanisms of venous leg 
ulcer development exist or similarly to carcinogenesis the co-existence 
of different precipitating factors leads to the development of the disease. 
To develop causative treatment opportunities for those who have genetic 
deficiencies in the pathogenesis, there is an emerging importance to 
characterize the genetic abnormalities of leg ulcer development. 
The difficulties of the studies regarding the molecular mechanisms of 
pathologic wound healing stem from the fact that these inherited factors 
form a complex multifactorial genetic background, which do not follow 
the Mendelian rules. Moreover each genetic component contributes 
differently to the pathogenesis of leg ulcers and the assessment of its 
importance in the development of leg ulcers is difficult and variable. To 
determine the putative genetic factors and to minimize statistical bias, 
the currently most widely accepted approach is the formation of highly 
homogenous subgroups of leg ulcer patients and assessment of the 
genetic factors within the subgroups. Therefore, a homogenous venous 
leg ulcer patient group has been selected with 157 individuals with non-
healing ulcers despite of proper therapy. The duration of the presence of 
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the leg ulcer exceeded 6 weeks. The female (48.4%) male (51.6%) ratio 
was nearly 1:1. The average duration of the ulcers was 5.8±5.1 years. 
The three most frequent and clinically relevant parameters in the history 
of the patients were: deep vein thrombosis, 29.9% of the leg ulcer 
patients had deep vein thrombosis previously. Leg fracture, 22.9% of 
the patients had leg fracture previously. Soft tissue infection of the 
affected lower leg, 47.1% of the patients had erysipelas or cellulites in 
their history. These clinical parameters strongly affect the circulation of 
the leg and contribute to the pathogenesis of venous leg ulcer 
development. Three subgroups of the patients have been created to 
further reduce statistical fluctuations Group A contained patients 
without thrombosis, fracture or soft tissue infection in the history. 
Patients with fracture, but without thrombosis and soft tissue infection 
has formed group B. While patients with thrombosis or erysipelas, but 
without fractures has been placed to group C. Other combinations of 
fracture, thrombosis and soft tissue infection were represented in such a 
small number that those patients as all put together in group D. Leg 
ulcer patients with diabetes of either type 1 or type 2 or with arterial 
disease were excluded from the study. Venous leg ulcer patients were 
also screened for cardiac diseases (incidence was 49.1%), 
atherosclerosis (incidence was 20.4%) and autoimmune disorders 
(incidence was 5.1%). The study was approved by the Internal Review 
Board. Written informed consent was obtained from all donors, and the 
study was conducted according to the Principles of the Declaration of 
Helsinki. 
The importance of several putative genetic factors has been assessed in 
the homogenous group of venous leg ulcer patients such as the G1691A 
factor V Leiden mutation, G20210A prothrombin gene mutation, 2451 
A/G polymorphism (SNP) of the FGFR2 gene and the -308 G/A SNP of 
the promoter region of the TNFα gene (Jebeleanu et al., 2001, Hafner et 
al., 2001; Nagy et al., 2005 and 2007). The investigations were carried 
out using RT-PCR with TaqMan probes and RFLP techniques described 
in details by previous studies (Jebeleanu  et al., 2001, Hafner et al., 
2001; Nagy et al., 2005 and 2007). The Leiden mutation was detected in 
a heterozygous form in 11 patients with the overall frequency of 7.9%, 
showing higher presentation in the group A and group C than in group B 
(data not shown). The prothrombin mutation occurred also only in 3 
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patients with heterozygous form, every other patients carried only the 
wild type allele (data not shown).  
The distribution of the mutant genotypes of the studied FGFR2 gene 
polymorphism (2451A/G SNP at the 3’UTR) was the highest in group A 
(ratio of homozygous mutants 18.8%, mutant allele frequency 
MAF=0.46), while the lowest in group B (ratio of homozygous mutants 
8.8%, MAF=0.37, Fisher Exact Probability Test P=0.12, Odds ratio 
1.49, CI 0.88 – 1.81;. However it has been proven previously, that the 
2451A/G polymorphism in the 3’UTR of the FGFR2 gene is associated 
with venous leg ulcer development, its distribution did not show 
significant difference between the subgroups of venous leg ulcer 
patients defined on the basis of their medical history. 
The single nucleotide change of the TNFα promoter also showed the 
highest frequency in group A (ratio of homozygous mutants 5.8%, 
MAF=0.22), while in group B and C homozygous mutant form was not 
detected and only the heterozygous form was present (group B 
MAF=0.18, group C MAF=0.11; group A vs. group B P=0.27, Odds 
ratio 1.35, CI 0.70 – 2.32; group A vs. group C P=0.017, Odds ratio 
2.38, CI 1.07 – 4.01). It has been demonstrated previously that the -
308A/G SNP of the promoter region of the TNFα gene is a predisposing 
factor to venous leg ulcer development (Wallace et al., 2006; Nagy et 
al., 2007). Our data demonstrate that the homozygous mutant form of 
the -308 TNFα SNP was represented in a significantly higher ratio 
among venous leg ulcer patients without other predisposing factor in 
their history (group A: no thrombosis, fracture or soft tissue infection) 
than among patients with other known etiological event in their history 
(group C: patients with previous thrombosis or soft tissue infection; 
group A vs. group C Fisher Exact Probability Test P=0.017). Our data 
further emphasize that the putative etiologic factors investigated in our 
study has a key importance in the development of therapy-resistant leg 
ulcer cases, and they might have a tremendous significance in the 
development of future causative treatment strategies. 
Several recent studies characterized in details putative genetic factors 
contributing to the development of leg ulcer. However these discoveries 
have no impact yet on the current guidelines of leg ulcer management 
and thus they have no clinical relevance yet. Further larger studies in 
different populations are needed to characterize the underlying genetic 
abnormalities in the mechanism of leg ulcer development and to work 
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out cost-effective investigation techniques for the routine diagnostic 
assessments of the putative genetic factors and causative treatment 
options for these patients. 
 
4.2. Local wound care studies 
Several methods and several media formulations have been published 
over the years for the separation and subsequent culturing of human 
epidermal melanocytes and keratinocytes (Eisinger at al, 1982; Gilchrest 
et al, 1984; Hu at al, 1957). With few exceptions, all methods used 
chemical mitogens to enhance cell growth. Co-cultures of melanocytes 
with keratinocytes in a melanocyte growth medium (MGM) 
supplemented with EGF, BPE, and FBS resulted in sufficient in vitro 
melanocyte growth without the need for chemical mitogens (Donatien et 
al, 1993). The use of basic fibroblast growth factor (bFGF), endothelin-
1 (ET-1) and α-melanocyte stimulating hormone (α-MSH) have also 
been reported to be able to replace the need for TPA and BPE in already 
established in vitro cultures of human neonatal melanocytes (Swope et 
al, 1995). The culture system that we describe here is unique, in that 
relatively long term, pure melanocyte cultures, with cells derived from 
adult epidermis, that are never exposed to chemical mitogens, can be 
established easily. Although additional growth factor supplementation 
(e.g. EGF, BPE) increases cell growth, the use of serum is sufficient to 
establish and maintain the in vitro culture of these cells in our medium. 
We found autologous human serum (AHS) to be somewhat superior to 
FBS in supporting the in vitro melanocyte growth. Cells expanded in 
vitro in Mel-mix supplemented with autologous human serum allow 
autologous transplantation of cultured skin cells in chronic wounds and 
in vitiligo (Lontz et al, 1994; Olsson et al, 1993; Olsson et al, 1995). We 
offer a novel culturing technique to isolate and culture human epidermal 
melanocytes and keratinocytes in a chemical mitogen-free environment. 
With this method it is possible to easily establish pure human epidermal 
skin cell cultures in which melanocytes propagate sufficiently already in 
the early passages, when their pigmentation is not lost, therefore they 
can be transplanted to cover vitiligo lesions. Further work will show 
whether the in vitro dedifferentiation of the cells that occurs in older 
cultures can be reversed with agents that allow autologous 
transplantations. Cells grown in our cultures regain their in vitro growth 
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after freezing and storage allowing repeated transplantation from the 
same harvest in chronic wound and vitiligo patients. 
In vitro culturing technique involves subcultivations to expand the 
number of keratinocytes. Transplantation techniques of cultured 
keratinocytes are based on the self-renewing capacity of the epidermis. 
This characteristic of the epidermis is the result of the presence of multi-
potent stem cells which reside in the bulge region of the hair follicle as 
well as in the interfollicular epidermis. Epidermal stem cells undergo 
asymmetric cell division and give rise to daughter stem cells and to 
transit amplifying cells. After a few rounds of cell division the transit 
amplifying cells exit from the cell cycle and undergo terminal 
differentiation. Differentiating keratinocytes constitute a significant 
percentage of the cultured keratinocytes separated from skin biopsies 
and in consequence have a finite replicative capacity and lifespan. The 
increased number of cell divisions in vitro leads to telomere shortening, 
which in turn reduces lifespan of the autograph, hence it is of outmost 
importance to use undifferentiated keratinocytes for autologous 
transplantation purposes (Counter et al, 2003). 
Stem cells and transit amplifying cells are characterized by expression 
of the transcription factor p63, a member of the p53 gene family. Recent 
data suggest that p63 has a role in initiating epithelial stratification 
during development and a role in maintaining the proliferative potential 
of basal keratinocytes in mature epidermis (Koster et al, 2004). As soon 
as the transit amplifying cells cease proliferation, the expression of p63 
is down-regulated and the cells start to produce K1 and K10 keratins. 
Production of K1 and K10 keratins mirrors the commitment to 
differentiation and is among the earliest events in the program of 
cellular terminal differentiation (Eichner et al, 1990). The proportion of 
p63 positive and K1/K10 negative cells in transplanted keratinocytes is 
important both for the short term and long term clinical outcome. 
We have shown that the epidermal cell suspension prepared from hairy 
scalp contains an abundance of undifferentiated keratinocytes as 
compared to conventional donor sites (groin, upper leg). Considering 
that stem cells are more abundant in hair follicles, the use of hairy scalp 
as a donor site provides a keratinocyte culture rich in undifferentiated 
keratinocytes (Taylor et al, 2000). Therefore, cell cultures prepared from 
hairy scalp skin specimens can proliferate to yield the required cell 
number for transplantation in a shorter period as compared to 
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conventional donor sites. Furthermore, the hairy-scalp derived cells 
have longer lifespan and longer regenerative capacities. The results 
reported here suggest that keratinocytes and melanocytes isolated and 
cultured from hairy scalp donor sites are more suitable for autologous 
transplantation of chronic leg ulcers and burnt skin areas than grafts 
established from conventional donor sites. Like other epidermal 
keratinocytes, the cultured cells can be successfully frozen and stored 
for possible future transplantations, an advantage that should prove 
useful both for patient and clinician. 
 
5. SUMMARY 
In our genetic studies we compared the SNP data of leg ulcer patients 
with healthy individuals for FGFR2-IIIb isoforms. Our results showed 
that FGFR2-IIIb exhibits a lower expression level in venous leg ulcer 
patients which results in the impairment of re-epithelisation, thus 
pathologic wound healing. The SNP data for the promoter region of the 
TNF-α gene suggested a primary association with obesity and only a 
secondary association with leg ulceration. We also set out to determine 
the expression abnormalities and/or gene polymorphisms of SDC4 and 
NRP1. We found out that SDC4 showed a significantly lower mRNA 
and protein expression levels in the uninvolved dermis of venous leg 
ulcer patients, compared with normal controls. In the case of NRP1 no 
expression abnormalities were detected. 
In our experiments regarding cell culturing we established a chemical 
and artificial mitogen free autologous keratinocyte/melanocyte culturing 
technique. We developed a special culture media to suit the needs of 
melanocytes as well as keratinocytes. This method enabled us to prepare 
autologous skin cell cultures suitable for the grafting of chronic wounds. 
Further, with the use of the hairy scalp as a donor site, we could 
establish cultures that consisted primarily of keratinocytes stem cells. 
This autologous skin cell culture was used for the grafting of chronic leg 
ulcers with the Tissucol® system. 
With the knowledge of our culturing results, we developed a split skin 
grafting technique for the transplantation of chronic leg ulcers. The split 
skin grafts taken from the hairy scalp were used for grafting with 
V.A.C. fixation of the grafts on the wound bed. With the combination of 
the hairy scalp and the V.A.C. technique all the grafts attached and 
vitalized on the wound bed. 
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